Literature DB >> 22319420

Suppressed wound healing in a patient with rheumatoid arthritis taking leflunomide (arava).

D Miller Wise.   

Abstract

Although patients with rheumatoid arthritis taking disease-modifying antirheumatic drugs (DMARDs) are monitored for various medication adverse events, DMARDs, and leflunomide in particular, have effects that are not observed clinically, specifically adverse effects on wound healing.

Entities:  

Year:  2011        PMID： 22319420      PMCID： PMC3267565          DOI： 10.7812/tpp/11-044

Source DB:  PubMed          Journal:  Perm J        ISSN： 1552-5767


  55 in total

1.  Brain abscess in rheumatoid arthritis.

Authors:  C-S Lee; C-K Chang
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

2.  Subacute cutaneous lupus erythematosus associated with leflunomide.

Authors:  O A Kerr; C S Murray; M J Tidman
Journal:  Clin Exp Dermatol       Date:  2004-05       Impact factor: 3.470

3.  Peripheral neuropathy in patients with systemic rheumatic diseases treated with leflunomide.

Authors:  C Metzler; A C Arlt; W L Gross; J Brandt
Journal:  Ann Rheum Dis       Date:  2005-12       Impact factor: 19.103

4.  [Development of dermatomyositis in a woman with rheumatoid arthritis treated with leflunomide].

Authors:  N Gómez Rodríguez; A Zulaica Garate
Journal:  An Med Interna       Date:  2005-06

5.  Leflunomide-associated tuberculosis?

Authors:  A Hocevar; B Rozman; S Praprotnik; B Lestan; D Erzen; V Petric; M Tomsic
Journal:  Rheumatology (Oxford)       Date:  2005-11-30       Impact factor: 7.580

6.  Multilayer reconstruction of abdominal wall defects with acellular dermal allograft (AlloDerm) and component separation.

Authors:  Adam R Kolker; Daniel J Brown; Jeremiah S Redstone; Vincent M Scarpinato; Marc K Wallack
Journal:  Ann Plast Surg       Date:  2005-07       Impact factor: 1.539

7.  Pulmonary abscess due to leflunomide use in rheumatoid arthritis: a case report.

Authors:  H Ulusoy; A Bilgici; O Kuru; C Celenk
Journal:  Rheumatol Int       Date:  2004-08-21       Impact factor: 2.631

8.  [Infections of the musculoskeletal system with chronic polyarthritis during a combination therapy with Methotrexate and Leflunomide].

Authors:  K S Delank; T Hansen; P Eysel; A Eckardt
Journal:  Z Orthop Ihre Grenzgeb       Date:  2002 Sep-Oct

9.  Leflunomide-induced acute hepatitis.

Authors:  C Sevilla-Mantilla; L Ortega; J A G Agúndez; B Fernández-Gutiérrez; J M Ladero; M Díaz-Rubio
Journal:  Dig Liver Dis       Date:  2004-01       Impact factor: 4.088

10.  The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism.

Authors:  H M Cherwinski; D McCarley; R Schatzman; B Devens; J T Ransom
Journal:  J Pharmacol Exp Ther       Date:  1995-01       Impact factor: 4.030
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.